Related Experiment Video
Updated: Jul 26, 2026

07:24
Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
Published on: January 23, 2018
10.3K
Tranexamic Acid in Mohs Micrographic Surgery: A Systematic Review
Eenika A Kumar1, Lisa M Morris2, Basia M Michalski-McNeely2
1University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Summary
Tranexamic acid (TXA) shows promise for hemostasis in Mohs surgery. This antifibrinolytic agent offers a safe and effective alternative to traditional methods, potentially improving patient outcomes and reducing bleeding.
Area of Science:
- Dermatology
- Surgical Oncology
- Pharmacology
Background:
- Tranexamic acid (TXA) is an established antifibrinolytic agent.
- Historically used for menorrhagia and bleeding disorders.
- Emerging applications in surgical procedures for hemostasis with a favorable safety profile.
Conclusions:
- Tranexamic acid (TXA) shows significant potential for improving patient outcomes in Mohs micrographic surgery (MMS).
- TXA may reduce surgical time and intraoperative/postoperative bleeding.
- Increased patient satisfaction is a potential benefit of using TXA.

